The Washington DC-based US pressure-group the Center for Public Integrity has attacked the Food and Drug Administration for allowing some staff to receive travel expenses paid for indirectly by drug firms. In a report published this week, the study's authors claim that $1.3 million of FDA travel costs since 1999 were paid by non-profit associations that receive substantial donations from drug companies.
Singled out for mention was the Drug Information Association, which allegedly paid for "more than 600 trips" taken by FDA employees. The travel payments were generally to allow FDA personnel to attend conferences, usually on technical issues. The CPI report can be found on-line at: www.publicintegrity.org and is titled Pushing Prescriptions.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze